The evaluation of potentially malignant disorders and oral cancers by non-invasive adjunctive technique
Keywords:
oral cancer, potentially malignant disorders, non-invasive adjunctive techniqueAbstract
An increased incidence of oral cancer is a major public health problem. The survival rate of patients with oral cancer is relatively low due to the fact that early lesions are not often visible and are difficult to detect, which results in delayed diagnosis and treatment. Furthermore, at present, lesions are usually diagnosed by the evaluation of clinical appearance in combination with the use of biopsy for histopathological evaluation which requires a high level of expertise from doctors. Accordingly, various methods, such as vital tissue staining, cytology, light-based detection system, salivary biomarkers, Raman spectroscopy, and Optical coherence tomography have been developed continuously to make the detection and diagnosis of the cancer more convenient, faster, and more accurate. This will not only improve the prognosis of the patients with oral cancer, but also reduce their risk of mortality.
References
1. Messadi DV. Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci 2013; 5(2): 59–65.
2. Johnson NW, Warnakulasuriya S, Gupta PC. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 2011; 23(2): 237–246.
3. กระทรวงสาธารณสุข กรมการแพทย์ สถาบันมะเร็งแห่งชาติ. ทะเบียนมะเร็งระดับโรงพยาบาล.กรุงเทพฯ: พรทรัพย์การพิมพ์; 2562.
4. Chakraborty D, Natarajan C, Mukherjee A. Advances in oral cancer detection. Adv Clin Chem 2019; 91: 181-200.
5. Omar E. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma-a systematic review. Head Face Med 2015;11: 6.
6. Rajmohan M, Rao MK, Joshua E, Rajasekaran ST, Kannan R. Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytology. J Oral MaxillofacPathol 2012; 16(3): 325-329.
7. Thomas J, Vineet DA, Rasheena PM, Krishnan JK. Early Detection of Precancerous and CancerousLesions: An Overview. National Journal of Integrateyd Research in Medicine:6(6); 95-101.
8. Charanya D, Raghupathy LP, Farzana AF, Murugan R, Krishnaraj R, Kalarani G. Adjunctive aids for the detection of oral premalignancy. J Pharm Bioallied Sci 2016; 8(Suppl 1): S13–S19.
9. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008; 44: 10-22.
10. Mashberg A. Tolonium (toluidine blue) rinse – A screening method for recognition of squamous carcinoma.Continuing study of oral cancer IV. JAMA 1981; 245: 2408–10.
11. Strome A, Kossatz S, Zanoni DK, Rajadhyaksha M, Patel S, Reiner T. Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening. Mol Imaging 2018; Jan-Dec: 17.
12. Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992; 21: 160–3.
13. Gupta,Shah JS, Parikh S, Limbdiwala P, Goel S. Clinical correlative study on early detection of oral cancer and precancerous lesions by modified oral brush biopsy and cytology followed by histopathology. J Cancer Res Ther 2014; 10(2): 232-8.
14. Mendes SF, Ramos GO, Rivero ER, Modolo F, Grando LJ, Meurer MI. Techniques for precancerous lesion diagnosis. J Oncol 2011; 2011: 326094.
15. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol 2009; 1(1): 5.
16. Meena A, Satoskar SK. Early Detection of Oral Pre-Cancerous Lesions:Recent Advances. Int J Med Public Health 2012; 2(3): 1-4.
17. Neha V, Ravikiran A, SamathaY,Purna CR, Ravindra N, Divy V. Chemiluminescence and Toluidine Blue as Diagnostic Tools for Detecting Early Stages of Oral Cancer: An invivo Study. J ClinDiagn Res 2014; 8(4): ZC35–ZC38.
18. Dongsuk S, Nadarajah V, Ann G, Rebecca RK. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol 2010; 6(7): 1143–1154.
19. Marco C, Gabriele C, Luca F, Cesare D, Giacomo O, Giuseppe T, et al. Early Diagnosis on Oral and Potentially Oral Malignant Lesions: A Systematic Review on the VELscope® Fluorescence Method. Dent J (Basel) 2019; 7(3): 93.
20. Esam O. Future Imaging Alternatives: The Clinical Non-invasive Modalities in Diagnosis of Oral Squamous Cell Carcinoma (OSCC). Open Dent J 2015; 9: 311-8.
21. Rafael MN. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 2009; 45(12): 1006-10.
22. Kaur J, Jacobs R, Huang Y, Salvo N, Politis C. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clin Oral Investig 2018;22(2):633-640.
23. Aditi S, Murali KC. Optical diagnostics in oral cancer: An update on Raman spectroscopic applications. J Cancer Res Ther 2017;13(6):908-915.
24. Singh S, Deshmukh A, Chaturvedi P, Krishna CM. In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa. J Biomed Opt 2012 ;17(10):105002.
25. Krishna H, Majumder SK, Chaturvedi P, Sidramesh M, Gupta PK.In vivo Raman spectroscopy for detection of oral neoplasia: A pilot clinical study. J Biophotonics 2014;7:690-702.
26. Guze K, Pawluk HC, Short M, Zeng H, Lorch J, Norris C, et al. Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. Head Neck 2015;37:511-7.
27. Malik A, Sahu A, Singh S, Deshmukh A, Chaturvedi P, Nair D, et al. In vivo Raman spectroscopy assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study. Head Neck 2017;39(11):2216-2223.
28. Hsieh YS, Ho YC, Lee SY, Chuang CC, Tsai JC, Lin KF, et al. Dental Optical Coherence Tomography. Sensors (Basel) 2013;13(7):8928–8949.
29. DeCoro M, Wilder-Smith P. Potential of optical coherence tomography for early diagnosis of oral malignancies. Expert Rev Anticancer Ther 2010;10(3):321–329.
30. Katkar RA, Tadinada SA, Amaechi BT, Fried D. Optical Coherence Tomography. Dent Clin North Am 2018;62(3):421-434.
31. Wilder-Smith P, Jung WG, Brenner M, Osann K, Beydoun H, Messadi D, et al. In vivo optical coherence tomography for the diagnosis of oral malignancy. Lasers Surg Med 2004;35(4):269-75.
32. Lee CK, Chi TT, Wu CT, Tsai MT, Chiang CP, Yang CC. Diagnosis of oral precancer with optical coherence tomography. Biomed Opt Express 2012;3(7):1632-1646.
2. Johnson NW, Warnakulasuriya S, Gupta PC. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 2011; 23(2): 237–246.
3. กระทรวงสาธารณสุข กรมการแพทย์ สถาบันมะเร็งแห่งชาติ. ทะเบียนมะเร็งระดับโรงพยาบาล.กรุงเทพฯ: พรทรัพย์การพิมพ์; 2562.
4. Chakraborty D, Natarajan C, Mukherjee A. Advances in oral cancer detection. Adv Clin Chem 2019; 91: 181-200.
5. Omar E. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma-a systematic review. Head Face Med 2015;11: 6.
6. Rajmohan M, Rao MK, Joshua E, Rajasekaran ST, Kannan R. Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytology. J Oral MaxillofacPathol 2012; 16(3): 325-329.
7. Thomas J, Vineet DA, Rasheena PM, Krishnan JK. Early Detection of Precancerous and CancerousLesions: An Overview. National Journal of Integrateyd Research in Medicine:6(6); 95-101.
8. Charanya D, Raghupathy LP, Farzana AF, Murugan R, Krishnaraj R, Kalarani G. Adjunctive aids for the detection of oral premalignancy. J Pharm Bioallied Sci 2016; 8(Suppl 1): S13–S19.
9. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol 2008; 44: 10-22.
10. Mashberg A. Tolonium (toluidine blue) rinse – A screening method for recognition of squamous carcinoma.Continuing study of oral cancer IV. JAMA 1981; 245: 2408–10.
11. Strome A, Kossatz S, Zanoni DK, Rajadhyaksha M, Patel S, Reiner T. Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening. Mol Imaging 2018; Jan-Dec: 17.
12. Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992; 21: 160–3.
13. Gupta,Shah JS, Parikh S, Limbdiwala P, Goel S. Clinical correlative study on early detection of oral cancer and precancerous lesions by modified oral brush biopsy and cytology followed by histopathology. J Cancer Res Ther 2014; 10(2): 232-8.
14. Mendes SF, Ramos GO, Rivero ER, Modolo F, Grando LJ, Meurer MI. Techniques for precancerous lesion diagnosis. J Oncol 2011; 2011: 326094.
15. Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol 2009; 1(1): 5.
16. Meena A, Satoskar SK. Early Detection of Oral Pre-Cancerous Lesions:Recent Advances. Int J Med Public Health 2012; 2(3): 1-4.
17. Neha V, Ravikiran A, SamathaY,Purna CR, Ravindra N, Divy V. Chemiluminescence and Toluidine Blue as Diagnostic Tools for Detecting Early Stages of Oral Cancer: An invivo Study. J ClinDiagn Res 2014; 8(4): ZC35–ZC38.
18. Dongsuk S, Nadarajah V, Ann G, Rebecca RK. Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol 2010; 6(7): 1143–1154.
19. Marco C, Gabriele C, Luca F, Cesare D, Giacomo O, Giuseppe T, et al. Early Diagnosis on Oral and Potentially Oral Malignant Lesions: A Systematic Review on the VELscope® Fluorescence Method. Dent J (Basel) 2019; 7(3): 93.
20. Esam O. Future Imaging Alternatives: The Clinical Non-invasive Modalities in Diagnosis of Oral Squamous Cell Carcinoma (OSCC). Open Dent J 2015; 9: 311-8.
21. Rafael MN. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol 2009; 45(12): 1006-10.
22. Kaur J, Jacobs R, Huang Y, Salvo N, Politis C. Salivary biomarkers for oral cancer and pre-cancer screening: a review. Clin Oral Investig 2018;22(2):633-640.
23. Aditi S, Murali KC. Optical diagnostics in oral cancer: An update on Raman spectroscopic applications. J Cancer Res Ther 2017;13(6):908-915.
24. Singh S, Deshmukh A, Chaturvedi P, Krishna CM. In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa. J Biomed Opt 2012 ;17(10):105002.
25. Krishna H, Majumder SK, Chaturvedi P, Sidramesh M, Gupta PK.In vivo Raman spectroscopy for detection of oral neoplasia: A pilot clinical study. J Biophotonics 2014;7:690-702.
26. Guze K, Pawluk HC, Short M, Zeng H, Lorch J, Norris C, et al. Pilot study: Raman spectroscopy in differentiating premalignant and malignant oral lesions from normal mucosa and benign lesions in humans. Head Neck 2015;37:511-7.
27. Malik A, Sahu A, Singh S, Deshmukh A, Chaturvedi P, Nair D, et al. In vivo Raman spectroscopy assisted early identification of potential second primary/recurrences in oral cancers: An exploratory study. Head Neck 2017;39(11):2216-2223.
28. Hsieh YS, Ho YC, Lee SY, Chuang CC, Tsai JC, Lin KF, et al. Dental Optical Coherence Tomography. Sensors (Basel) 2013;13(7):8928–8949.
29. DeCoro M, Wilder-Smith P. Potential of optical coherence tomography for early diagnosis of oral malignancies. Expert Rev Anticancer Ther 2010;10(3):321–329.
30. Katkar RA, Tadinada SA, Amaechi BT, Fried D. Optical Coherence Tomography. Dent Clin North Am 2018;62(3):421-434.
31. Wilder-Smith P, Jung WG, Brenner M, Osann K, Beydoun H, Messadi D, et al. In vivo optical coherence tomography for the diagnosis of oral malignancy. Lasers Surg Med 2004;35(4):269-75.
32. Lee CK, Chi TT, Wu CT, Tsai MT, Chiang CP, Yang CC. Diagnosis of oral precancer with optical coherence tomography. Biomed Opt Express 2012;3(7):1632-1646.
Downloads
Published
2021-08-31
How to Cite
1.
Tanya M. The evaluation of potentially malignant disorders and oral cancers by non-invasive adjunctive technique. udhhosmj [internet]. 2021 Aug. 31 [cited 2026 Mar. 19];29(2):304-13. available from: https://he02.tci-thaijo.org/index.php/udhhosmj/article/view/253276
Issue
Section
Academic Article
License
การละเมิดลิขสิทธิ์ถือเป็นความรับผิดชอบของผู้ส่งบทความโดยตรง
ผลงานที่ได้รับการตีพิมพ์ถือเป็นลิขสิทธิ์ของผู้นิพนธ์ ขอสงวนสิทธิ์มิให้นำเนื้อหา ทัศนะ หรือข้อคิดเห็นใด ๆ ของบทความในวารสารไปเผยแพร่ทางการค้าก่อนได้รับอนุญาตจากกองบรรณาธิการ อย่างเป็นลายลักษณ์อักษร
